Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4315756 | 0.88 | OPRM1 (0.50) | OPRM1OPRD1 | |
| SCHEMBL4315754 | 0.88 | OPRM1 (0.50) | OPRM1OPRD1 | |
| SCHEMBL21067778 | 0.88 | OPRM1 (0.50) | OPRM1OPRD1 | |
| SCHEMBL21581733 | 0.80 | OPRM1 (0.53) | OPRM1OPRD1 | |
| SCHEMBL30431027 | 0.80 | OPRM1 (0.61) | OPRM1OPRD1 | |
| SCHEMBL21581706 | 0.79 | OPRM1 (0.54) | OPRM1OPRD1 | |
| SCHEMBL13563448 | 0.77 | OPRM1 (0.66) | OPRM1OPRD1 | |
| SCHEMBL29037548 | 0.77 | OPRM1 (0.66) | OPRM1OPRD1 | |
| SCHEMBL13563441 | 0.77 | OPRM1 (0.66) | OPRM1OPRD1 | |
| SCHEMBL31347655 | 0.77 | OPRM1 (0.66) | OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002038796-A9 | METHODS FOR DETERMINING PROTEASE CLEAVAGE SITE MOTIFS | BETH ISRAEL HOSPITAL (US) | 2004-04-29 | — | — | WO | claimed |
| WO-2002038796-A2 | METHODS FOR DETERMINING PROTEASE CLEAVAGE SITE MOTIFS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2002-05-16 | — | — | WO | claimed |
| WO-2002038796-A9 | METHODS FOR DETERMINING PROTEASE CLEAVAGE SITE MOTIFS | BETH ISRAEL HOSPITAL (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2002038796-A2 | METHODS FOR DETERMINING PROTEASE CLEAVAGE SITE MOTIFS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2002-05-16 | — | — | WO | disclosed |